New gene therapy injection targets Parkinson's at its genetic root
NCT ID NCT07414290
First seen Feb 18, 2026 · Last updated May 05, 2026 · Updated 8 times
Summary
This early-stage study tests a new gene therapy called VGN-R08b for people with Parkinson's disease who have a specific mutation in the GBA1 gene. The treatment is given as a single injection into the fluid around the brain. The main goals are to check safety and see if it can improve symptoms or slow the disease. Only 17 participants aged 30 to 70 will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xiangya Hospital, Central South University
Changsha, Hunan, 410008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.